MolMed now part of AGC Biologics | LinkedIn
Piazza Affari: Molmed scende verso 0,4305 Euro
Azioni Molecular Medicine in Borsa | Quotazione F: 4HW - Investing.com
Molmed, opa della giapponese Agc per la biotech italiana Molmed - Wired | Wired Italia
MolMed - Wikipedia
Will MolMed soon have its first Cell therapy on the Market?
Piazza Affari: con l'OPA MolMed offre (ancora) rendimento del 10% | Investire.biz
Small Cap Conference 2013: listed SMEs meet investors at Borsa Italiana
MolMed: il modello vincente della biotech italiana - AboutPharma
Molmed verso delisting. Successo dell'OPA promossa da AGC
MOLMED S.P.A. : MLM Stock Price | IT0001080248 | MarketScreener
MolMed: Contact Details and Business Profile
MolMed - YouTube
MolMed now part of AGC Biologics | Iterate.ai
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHER
IPO e altre ammissioni - 2008 - Borsa Italiana
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHER
MolMed - YouTube
Azioni Molmed: ha ragione Banca Imi o il mercato?
Relazione sulla remunerazione Molecular Medicine S.p.A.
COMUNICATO STAMPA
OFFERTE PUBBLICHE DI ACQUISTO
Overview of the Italian Primary Markets
